Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients

BACKGROUND: Treatment options in older acute myeloid leukaemia (AML) patients include intensive chemotherapy, best supportive care (BSC), and hypomethylating agents. Currently, limited data is available on hypomethylating agents in older AML patients in unselected patient populations. METHODS: To co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van der Helm, Lieke H, Scheepers, Ellen RM, Veeger, Nic JGM, Daenen, Simon MGJ, Mulder, André B, van den Berg, Eva, Vellenga, Edo, Huls, Gerwin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3639930/
https://ncbi.nlm.nih.gov/pubmed/23587459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-29
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados